TY - JOUR
T1 - Fluorescence-guided bone resection by using Visually Enhanced Lesion Scope in diffuse chronic sclerosingosteomyelitis of the mandible
T2 - Clinical and pathological evaluation
AU - Yoshiga, Daigo
AU - Sasaguri, Masaaki
AU - Matsuo, Kou
AU - Yoshida, Sei
AU - Uehara, Masataka
AU - Habu, Manabu
AU - Haraguchi, Kazuya
AU - Tanaka, Tatsurou
AU - Morimoto, Yasuhiro
AU - Yoshioka, Izumi
AU - Tominaga, Kazuhiro
N1 - Publisher Copyright:
© Medicina Oral S.L.
PY - 2015
Y1 - 2015
N2 - Diffuse chronic sclerosingosteomyelitis (DCSO) is a refractory disease, becausethe etiology and pathogenesis remain poorly understood and to determine the border betweenunhealthy boneandhealthybone is difficult. However, progressive inflammation, clinical symptoms and a high recurrence rate of DCSO were the reasons for surgical treatment. We report a case of a 66-year old woman with DCSO of the right side of mandible who was treated with hemimandibulectomy and simultaneous reconstruction by vascularized free fibula flap. After preoperative administration of minocycline for 1 month, the bone fluorescence was successfully monitored by using a Visually Enhanced Lesion Scope (VELscope®). Intraoperatively, we could determine the resection boundaries. We investigated the clinical and histopathological findings. The fluorescence findings were well correlated with histopathological findings. Using a VELscope®was handy and useful to determine the border between DCSO lesion andhealthybone. The free fibula flap under the minocycline-derived bone fluorescence by using a VELscope®offered a good quality of mandibular bone and the successful management of an advanced and refractory DCSO.
AB - Diffuse chronic sclerosingosteomyelitis (DCSO) is a refractory disease, becausethe etiology and pathogenesis remain poorly understood and to determine the border betweenunhealthy boneandhealthybone is difficult. However, progressive inflammation, clinical symptoms and a high recurrence rate of DCSO were the reasons for surgical treatment. We report a case of a 66-year old woman with DCSO of the right side of mandible who was treated with hemimandibulectomy and simultaneous reconstruction by vascularized free fibula flap. After preoperative administration of minocycline for 1 month, the bone fluorescence was successfully monitored by using a Visually Enhanced Lesion Scope (VELscope®). Intraoperatively, we could determine the resection boundaries. We investigated the clinical and histopathological findings. The fluorescence findings were well correlated with histopathological findings. Using a VELscope®was handy and useful to determine the border between DCSO lesion andhealthybone. The free fibula flap under the minocycline-derived bone fluorescence by using a VELscope®offered a good quality of mandibular bone and the successful management of an advanced and refractory DCSO.
UR - http://www.scopus.com/inward/record.url?scp=84946411517&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84946411517&partnerID=8YFLogxK
U2 - 10.4317/jced.52268
DO - 10.4317/jced.52268
M3 - Article
AN - SCOPUS:84946411517
SN - 1989-5488
VL - 7
SP - e548-e551
JO - Journal of Clinical and Experimental Dentistry
JF - Journal of Clinical and Experimental Dentistry
IS - 4
M1 - 52268
ER -